These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7205938)

  • 1. A single cell marker of active NK cytotoxicity: only a fraction of target binding lymphocytes are killer cells.
    Targan S; Grimm E; Bonavida B
    J Clin Lab Immunol; 1980 Nov; 4(3):165-8. PubMed ID: 7205938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reorientation of the Golgi apparatus and the microtubule-organizing center in the cytotoxic effector cell is a prerequisite in the lysis of bound target cells.
    Kupfer A; Dennert G; Singer SJ
    J Mol Cell Immunol; 1985; 2(1):37-49. PubMed ID: 3880506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC; Britvan L; Targan SR
    J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of natural killer cells in pregnancy. I. Analysis at the single cell level.
    Toder V; Nebel L; Gleicher N
    J Clin Lab Immunol; 1984 Jul; 14(3):123-7. PubMed ID: 6207299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heterogeneity of a KU-2 cell line derived from human renal cell carcinoma--differential susceptibilities of its sublines to NK cell-mediated cytotoxicity].
    Hayakawa M; Osawa A; Nagakura K; Kikuchi H
    Hinyokika Kiyo; 1985 May; 31(5):763-8. PubMed ID: 4050622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of natural killer cell cytotoxic activity after interaction with target cells.
    Perussia B; Trinchieri G
    J Immunol; 1981 Feb; 126(2):754-8. PubMed ID: 7451993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
    Roozemond RC; Mevissen M; Urli DC; Bonavida B
    J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population distributions of natural killer and K562 target cell conjugates.
    Garcia-Peñarrubia P; Koster FT; Bankhurst AD
    Nat Immun Cell Growth Regul; 1989; 8(2):57-65. PubMed ID: 2668745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of natural killing by a glycopeptide isolated from the K562 plasma membrane.
    Targan S; Decker JM; Ades EW
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):113-23. PubMed ID: 6438498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200.
    Targan SR; Newman W
    J Immunol; 1983 Sep; 131(3):1149-53. PubMed ID: 6886418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
    Hagner G
    Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.